All stock lists
New York Times Co (New York Stock Exchange:NYT)
US · Delayed Price · Currency is USD
69.58+0.16 (+0.23%)
Insider Score
––Not scored
NYT Insider Score
Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
NYT analyst forecast
NYT analyst consensus
Moderate Buy4 ratings
Buy 2 Hold 2 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
NYT 12-month price target
$75.00+7.2% upsideaverage of 1 firm
$75.00High
$75.00Low
Best analysts covering NYT
- JP Morgan100%success rate · 6 calls
- Evercore ISI Group100%success rate · 3 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
NYT analyst ratings
| Analyst | Firm | Rating | Price target | Upside | Action | Date |
|---|---|---|---|---|---|---|
| Morgan Stanley | Equal Weight | $75.00 | +13.1% | Reiterated | 2026-10-12 | |
| — | Guggenheim | Buy | — | — | Upgraded | 2026-09-15 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2026-08-06 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2026-08-06 |
| — | B of A Securities | Neutral | — | — | Reiterated | 2026-06-24 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-05-29 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2026-05-07 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2026-05-07 |
| — | Guggenheim | Neutral | — | — | Reiterated | 2026-05-07 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-03-24 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-02-05 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2026-02-05 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-02-05 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2026-01-20 |
| — | Citigroup | Buy | — | — | Reiterated | 2025-12-23 |
| — | Citigroup | Buy | — | — | Reiterated | 2025-11-13 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2025-11-06 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2025-11-06 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2025-11-06 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2025-08-08 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2025-08-07 |
| — | Guggenheim | Neutral | — | — | Reiterated | 2025-08-07 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2025-08-07 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2025-08-07 |
| — | Guggenheim | Neutral | — | — | Reiterated | 2025-06-02 |
| — | Guggenheim | Neutral | — | — | Reiterated | 2025-05-08 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2025-02-06 |
| — | Deutsche Bank | Buy | — | — | Reiterated | 2024-11-05 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2024-11-05 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2024-08-08 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2024-08-08 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2024-05-09 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2023-11-09 |
| — | Guggenheim | Neutral | — | — | Reiterated | 2023-08-10 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2023-08-09 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2023-08-09 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2023-08-09 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2023-07-12 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2023-05-12 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2023-03-15 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2023-02-09 |
| — | Barclays | Equal Weight | — | — | Upgraded | 2023-02-09 |
| — | Morgan Stanley | Equal Weight | — | — | Downgraded | 2022-12-16 |
| — | Cannonball Research | Neutral | — | — | Downgraded | 2022-09-02 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2022-08-04 |
| — | Guggenheim | Neutral | — | — | Reiterated | 2022-07-21 |
| — | Cannonball Research | Neutral | — | — | Downgraded | 2022-06-22 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2022-06-21 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2022-06-14 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2022-06-14 |
| — | Barclays | Underweight | — | — | Reiterated | 2022-06-14 |
| — | Wolfe Research | Peer Perform | — | — | Downgraded | 2021-12-06 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2021-11-02 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2021-02-05 |
| — | Evercore ISI Group | Outperform | — | — | Upgraded | 2020-11-09 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2020-10-14 |
| — | Wolfe Research | Outperform | — | — | Reiterated | 2020-08-27 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2020-06-15 |
| — | CFRA | Buy | — | — | Upgraded | 2020-05-06 |
| — | Evercore ISI Group | In Line | — | — | Downgraded | 2020-04-23 |
NYT earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-04 | 0.88 | 0.89 | $791.3M | $802.3M |
| 2026-05-06 | 0.47 | 0.61 | $699.9M | $712.2M |
| 2026-08-05 | 0.66 | 0.69 | $752.0M | $762.5M |
| 2026-11-04 | 0.64 | 0.00 | $767.2M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.